Abstract
Transbronchial needle aspiration biopsy (TBNA) was developed in the 1980’s as a technique for mediastinal and hilar lymph node biopsy. This offered pulmonologists and patients a minimally invasive technique for mediastinal non-small cell lung cancer staging and served as an alternative to surgical mediastinoscopy. Over the last few decades there are new additions to this technique using guided TBNA with endobronchial ultrasound (EBUS) and the use navigational bronchoscopy for peripheral lung TBNA. The future of TBNA may potentially transition from a diagnostic tool to a therapeutic instrument by locally injecting medications.
Keywords: Bronchoscopy, transbronchial needle aspiration.
Current Respiratory Medicine Reviews
Title:Transbronchial Needle Aspiration (TBNA): Past Present and Future
Volume: 10 Issue: 3
Author(s): C. Gilbert, R. Ortiz, Y. Ma, H.J. Lee, L. Yarmus and K. Wang
Affiliation:
Keywords: Bronchoscopy, transbronchial needle aspiration.
Abstract: Transbronchial needle aspiration biopsy (TBNA) was developed in the 1980’s as a technique for mediastinal and hilar lymph node biopsy. This offered pulmonologists and patients a minimally invasive technique for mediastinal non-small cell lung cancer staging and served as an alternative to surgical mediastinoscopy. Over the last few decades there are new additions to this technique using guided TBNA with endobronchial ultrasound (EBUS) and the use navigational bronchoscopy for peripheral lung TBNA. The future of TBNA may potentially transition from a diagnostic tool to a therapeutic instrument by locally injecting medications.
Export Options
About this article
Cite this article as:
Gilbert C., Ortiz R., Ma Y., Lee H.J., Yarmus L. and Wang K., Transbronchial Needle Aspiration (TBNA): Past Present and Future, Current Respiratory Medicine Reviews 2014; 10 (3) . https://dx.doi.org/10.2174/1573398X10666141118232214
DOI https://dx.doi.org/10.2174/1573398X10666141118232214 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pathophysiological Role of Mitochondrial Potassium Channels and their Modulation by Drugs
Current Medicinal Chemistry Heat Shock Proteins in Cancer: Signaling Pathways, Tumor Markers and Molecular Targets in Liver Malignancy
Protein & Peptide Letters Blocking Apoptotic Intracellular Signaling Cascades with Cell-Permeable Peptides
Current Signal Transduction Therapy Identification of Inflammatory, Metabolic, and Cell Survival Pathways Contributing to Cerebral Small Vessel Disease by Postmortem Gene Expression Microarray
Current Neurovascular Research Lipid Resuscitation: A Life-Saving Antidote for Local Anesthetic Toxicity
Current Pharmaceutical Biotechnology Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale
Current Organic Chemistry LINE-1 Methylation is Associated with an Increased Risk of Ischemic Stroke in Men
Current Neurovascular Research Pluronic-Based Core/Shell Nanoparticles for Drug Delivery and Diagnosis
Current Medicinal Chemistry From Anreps Phenomenon to Myocardial Hypertrophy: Role of the Na+/H+ Exchanger
Current Cardiology Reviews A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update
Current Medicinal Chemistry Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine Recent Patents on Mesenchymal Stem Cell Mediated Therapy in Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Gene Delivery for Periodontal Tissue Engineering: Current Knowledge – Future Possibilities
Current Gene Therapy Perspective of Molecular Hydrogen in the Treatment of Sepsis
Current Pharmaceutical Design Aldose Reductase, Oxidative Stress and Diabetic Cardiovascular Complications
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects of Medroxyprogesterone Acetate on the Risk of Cardiovascular Disease in Postmenopausal Women Receiving Estrogen
Vascular Disease Prevention (Discontinued) Restoring the Dysfunctional Endothelium
Current Pharmaceutical Design Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Current Pharmaceutical Design Kinins as Therapeutic Agents in Cardiovascular and Renal Diseases
Current Pharmaceutical Design